Monograph Pharma — Global Pharmaceutical Sourcing, CDMO & Licensing Partner
We Care Your Health
A single-point pharmaceutical partner — from India's manufacturing strength to global markets.
Monograph Pharma delivers high-quality medicines across niche and generic segments — backed by integrated sourcing, CDMO, licensing, regulatory, and facility capabilities, and partnerships built on collaboration and integrity.
Backed by our joint venture with Zeino Pharma FZ LLC, Monograph Pharma builds a niche-to-generic pharmaceutical portfolio bringing superior-quality, affordable medicines to patients across the GCC, MENA, Africa, CIS, Southeast Asia, Asia Pacific, and Latin America.
Strategic Joint Venture
Zeino Pharma, UAE
Our Core Services
Comprehensive support across the pharmaceutical value chain
Global Presence
Strategic reach across regulated, semi-regulated, and emerging markets
Our Clients
We are proud to have worked with a diverse range of clients across various industries. Here are some of the organizations we have had the privilege to serve.
What Our Partners Say
Real feedback from the manufacturers and partners we work with
Frequently Asked Questions
Authoritative, answer-first insights into our international pharmaceutical sourcing, CDMO processes, EU/WHO-GMP compliance, and joint venture infrastructure.
Monograph Pharma is an integrated pharmaceutical sourcing, CDMO, and consultancy partner headquartered in Hyderabad, India. In joint venture with Zeino Pharma UAE, the company delivers end-to-end solutions across global pharmaceutical sourcing, contract development and manufacturing (CDMO), CTD/eCTD dossier licensing, regulatory compliance consulting, and turnkey cleanroom facility engineering for international markets.
Monograph Pharma manages contract development and manufacturing (CDMO) projects with single-point accountability. The process encompasses pre-formulation screening, analytical method development, pilot batch scale-up, ICH-compliant stability testing, technology transfer, and commercial-scale batch manufacturing, helping brand owners bring high-quality generic and novel formulations to market with reduced lead times and capital efficiency.
All pharmaceutical formulations supplied by Monograph Pharma are manufactured exclusively in audited facilities compliant with cGMP standards. Partner manufacturing suites hold active WHO-GMP certifications, with key facility lines audited by Stringent Regulatory Authorities (SRAs) including the US FDA, EU-GMP, PIC/S, and regional health ministries, ensuring rigorous analytical testing, stability data, and batch documentation.
Monograph Pharma provides submission-ready Common Technical Document (CTD) and electronic CTD (eCTD) dossiers spanning Modules 1 through 5, supported by complete bioequivalence (BE) studies, analytical method validations, and Zone IVb stability data. Our regulatory affairs team assists client partners through regional health authority submissions, query responses, and Marketing Authorization (MA) transfers across the GCC, MENA, CIS, and emerging markets.
Monograph Pharma provides a diversified portfolio of over 300 pharmaceutical products across generic and specialty segments. The catalogue spans oral solids (tablets, capsules, orally disintegrating tablets), modified-release pellets and granules, sterile parenterals, lyophilized injectables, oral liquids, topical semi-solids, and specialized nutraceutical formulations manufactured in strict compliance with international pharmacopeias.
Yes. Monograph Pharma delivers complete private labeling and bespoke packaging solutions tailored to client brand guidelines and regional language requirements. All commercial packaging lines feature 2D DataMatrix track-and-trace serialization, GS1 barcodes, and tamper-evident closures in compliance with international anti-counterfeiting regulations and national track-and-trace systems.
Monograph Pharma operates in a formal strategic joint venture with Zeino Pharma FZ LLC, an established scientific center and Marketing Authorization Holder (MAH) located in Dubai Science Park, UAE. This cross-border alliance combines India's formulation development speed and SRA/WHO-GMP manufacturing strength with Zeino Pharma's commercial presence and direct regulatory access across the GCC and MENA regions.
International distributors, ministries of health, hospital procurement agencies, and private brand owners can partner with Monograph Pharma by submitting commercial inquiries directly through our online portal or via email at bd@monographpharma.com. Our business development team provides techno-commercial evaluations, dossier reviews, sample shipments, and supply agreements within 1–2 business days.
Have a Specific Regulatory, Sourcing, or Dossier Requirement?
Our business development and regulatory affairs desk provides custom feasibility assessments, dossier reviews, and techno-commercial proposals within 1–2 business days.
Contact Us
Connect with our global business development and regulatory team for sourcing, licensing, CDMO, and distribution partnerships.

